Critically ill patients often acquire neuropathy and/or myopathy labeled ICU-acquired
weakness. The current insights into incidence, pathophysiology, diagnostic tools, risk …

A substantial number of patients admitted to the ICU because of an acute illness,
complicated surgery, severe trauma, or burn injury will develop a de novo form of muscle …

Critical illness polyneuropathies (CIP) and myopathies (CIM) are common complications of
critical illness. Several weakness syndromes are summarized under the term intensive care …

Intensive care unit–acquired weakness (ICU-AW) is the most common neuromuscular
impairment in critically ill patients. We discuss critical aspects of ICU-AW that have not been …

Neuromuscular complications of critical illness are common, and can be severe and
persistent, with substantial impairment in physical function and long-term quality of life …

Neuromuscular abnormalities culminating in skeletal-muscle weakness occur very
commonly in critically ill patients. Intensive-care-unit (ICU) acquired neuromuscular …

ICU-acquired weakness (ICUAW) occurs with reported incidence rates from 25% to 100%.
Risk factors include immobility, sepsis, persistent systemic inflammation, multiorgan system …

Although Sir William Osler reported a “rapid loss of the flesh” in patients with prolonged
sepsis as early as 1892, the cause of neuromuscular weakness associated with critical …

Intensive care unit-acquired weakness (ICU-AW), a common neuromuscular complication
associated with patients in the ICU, is a type of skeletal muscle dysfunction that commonly …

Background Muscular weakness and/or muscle wasting is recognized as a key medical
problem in critically ill patients on intensive care units (ICUs) worldwide. Methods and …